Pre-order Enquiry
Request Free Sample
Europe Topical Corticosteroids Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024
SKU ID : DBMR-11617939 | Publishing Date : 01-Nov-2017 | No. of pages : 350
Detailed TOC of Europe Topical Corticosteroids Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024
TABLE OF CONTENTS1. INTRODUCTION 32
1.1. OBJECTIVES OF THE STUDY 32
1.2. MARKET DEFINITION 32
1.3. OVERVIEW OF EUROPE TOPICAL CORTICOSTEROIDS MARKET 32
1.4. CURRENCY AND PRICING 33
1.5. LIMITATION 33
1.6. MARKETS COVERED 34
2. MARKET SEGMENTATION 38
2.1. MARKETS COVERED 38
2.2. GEOGRAPHIC SCOPE 40
2.3. YEARS CONSIDERED FOR THE STUDY 41
2.4. CURRENCY AND PRICING 41
2.5. RESEARCH METHODOLOGY 42
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 46
2.7. SECONDARY SOURCES 47
2.8. ASSUMPTIONS 47
3. MARKET OVERVIEW 48
3.1. DRIVERS 49
3.1.1. INCREASING PREVALENCE OF CHRONIC DISEASE OR CONDITION 49
3.1.2. GROWING NUMBER OF GERIATRIC POPULATION 49
3.1.3. GROWTH IN DEMAND OF TOPICAL DRUG DELIVERY DRUGS 49
3.1.4. INCREASING INVESTMENT IN RESEARCH AND DEVELOPMENT 50
3.1.5. NEW PRODUCT LAUNCHESBY KEY PLAYERS 50
3.2. RESTRAINTS 50
3.2.1. EXPIRY OF PATENT FOR DRUGS 50
3.2.2. WEAK REIMBURSEMENT POLICIES 50
3.2.3. STRINGENT REGULATORY POLICIES 51
3.3. OPPORTUNITIES 51
3.3.1. HIGH INVESTMENTS IN R&D TO INNOVATE NEW PRODUCTS 51
3.3.2. LUCRATIVE OPPORTUNITIES IN EMERGING MARKET 51
3.3.3. INCREASING MERGERS AND ACQUISITIONS 51
3.4. CHALLENGES 52
3.4.1. PRICING PRESSURE BY GOVERNMENT 52
3.4.2. SIDE EFFECTSOF TOPICAL CORTICOSTEROIDS 53
4. EXECUTIVE SUMMARY 54
5. PREMIUM INSIGHTS 56
6. EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME 59
6.1. OVERVIEW 60
6.2. FLUDROXYCORTIDE 62
6.3. TRIAMCINOLONE ACETONIDE 63
6.4. FLUOCINOLONE ACETONIDE 64
6.5. ANTISEPTICS 65
6.6. BETAMETHASONE 66
6.7. CLOBETASONE PROPIONATE 67
6.8. CLOBETASONE BUTYRATE 68
6.9. HALOBETASONE 69
6.10. MOMETASONE 70
6.11. OTHERS 71
7. EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS 72
7.1. OVERVIEW 73
7.2. ULTRA HIGH 75
7.2.1. CLOBETASOL PROPIONATE 76
7.2.2. DIFLORASONE DIACETATE 76
7.2.3. BETAMETHASONE DIPROPIONATE GLYCOL 76
7.3. HIGH 77
7.3.1. AMCINONIDE 78
7.3.2. BETAMETHASONE DIPROPIONATE 78
7.3.3. DESOXIMETASONE 78
7.3.4. FLUOCINONIDE 78
7.3.5. OTHERS 79
7.4. MODERATE 79
7.4.1. DESOXIMETASONE 80
7.4.2. FLUOCINOLONE ACETONIDE 80
7.4.3. FLUDROXYCORTIDE 81
7.4.4. HYDROCORTISONE VALERATE 81
7.4.5. TRIAMCINOLONE ACETONIDE 81
7.4.6. CLOBETASONE BUTYRATE 81
7.4.7. OTHERS 81
7.5. MILD 82
7.5.1. HYDROCORTISONE 83
7.5.2. HYDROCORTISONE ACETATE 83
7.5.3. BETAMETHASONE VALERATE 83
7.5.4. DESONIDE 84
7.5.5. FLUOCINOLONE ACETONIDE 84
7.5.6. OTHERS 84
8. EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION 85
8.1. OVERVIEW 86
8.2. ACNE 88
8.3. DERMATITIS 89
8.4. PSORIASIS 89
8.5. SKIN INFECTION 91
8.6. HYPERPIGMENTATION 92
8.7. MELASMA 93
8.8. OTHERS 94
9. EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE 95
9.1. OVERVIEW 96
9.2. OINTMENTS 98
9.3. CREAMS 99
9.4. LIQUID & SOLUTIONS 100
9.5. LOTIONS 101
9.6. GEL 102
9.7. OILS 103
9.8. PASTES 104
9.9. SPRAYS 105
9.10. OTHERS 106
10. EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY END-USER 107
10.1. OVERVIEW 108
10.2. HOSPITAL 110
10.3. DERMATOLOGY CLINICS 111
10.4. HOMECARE 112
10.5. OTHERS 113
11. EUROPE TOPICAL CORTICOSTEROIDS MARKET,
BY DISTRIBUTION CHANNEL 114
11.1. OVERVIEW 115
11.2. HOSPITAL PHARMACIES 117
11.3. PHARMACY STORES 118
11.4. ONLINE PHARMACIES 119
11.5. OTHERS 120
12. EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE 121
12.1. OVERVIEW 122
12.2. OVER THE COUNTER (OTC) BASED 124
12.3. PRESCRIPTION BASED 125
13. EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY BRANDS 126
13.1. OVERVIEW 127
13.2. BETNOVATE 127
13.3. BETNOVATE N 127
13.4. PANDERM PLUS 128
13.5. LOBATE 128
13.6. COSVATE G 128
13.7. CLOP G 128
13.8. TENOVATE GN 128
13.9. LOBATE GM 128
13.10. ULTIDERM 128
13.11. FLUTIVATE 129
13.12. FEXIN 129
13.13. MOMATE 129
13.14. CANDIDERM 129
13.15. OTHERS 129
14. EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY GEOGRAPHY 130
14.1. OVERVIEW 131
14.2. EUROPE 167
14.2.1. GERMANY 179
14.2.2. FRANCE 184
14.2.3. U.K. 189
14.2.4. ITALY 194
14.2.5. SPAIN 199
14.2.6. RUSSIA 204
14.2.7. TURKEY 209
14.2.8. BELGIUM 214
14.2.9. NETHERLANDS 219
14.2.10. SWITZERLAND 224
14.2.11. REST OF EUROPE 229
15. EUROPE TOPICAL CORTICOSTEROIDS MARKET, COMPANY LANDSCAPE 331
15.1. COMPANY SHARE ANALYSIS: EUROPE 331
16. COMPANY PROFILES 335
16.1. GLAXOSMITHKLINE PLC. 335
16.1.1. COMPANY OVERVIEW 335
16.1.2. GLAXOSMITHKLINE PLC: REVENUE ANALYSIS 335
16.1.3. PRODUCT PORTFOLIO 336
16.1.4. RECENT DEVELOPMENTS 336
16.2. MERCK & CO. INC. 337
16.2.1. COMPANY OVERVIEW 337
16.2.2. MERCK & CO. INC.: REVENUE ANALYSIS 337
16.2.3. PRODUCT PORTFOLIO 338
16.2.4. RECENT DEVELOPMENTS 338
16.3. LEO PHARMA 339
16.3.1. COMPANY OVERVIEW 339
16.3.2. LEO PHARMA: REVENUE ANALYSIS 339
16.3.3. PRODUCT PORTFOLIO 340
16.3.4. RECENT DEVELOPMENTS 340
16.4. ALMIRALL S.A. 341
16.4.1. COMPANY OVERVIEW 341
16.4.2. ALMIRALL S.A.: COMPANY SNAPSHOT 341
16.4.3. PRODUCT PORTFOLIO 342
16.4.4. RECENT DEVELOPMENTS 342
16.5. VALEANT PHARMACEUTICALS INTERNATIONAL 343
16.5.1. COMPANY OVERVIEW 343
16.5.2. VALEANT PHARMACEUTICALS INTERNATIONAL: REVENUE ANALYSIS 343
16.5.3. PRODUCT PORTFOLIO 344
16.5.4. RECENT DEVELOPMENTS 344
16.6. ZYLERA PHARMACEUTICALS 345
16.6.1. COMPANY OVERVIEW 345
16.6.2. ZYLERA PHARMACEUTICALS: COMPANY SNAPSHOT 345
16.6.3. PRODUCT PORTFOLIO 346
16.6.4. RECENT DEVELOPMENTS 346
16.7. SANDOZ INTERNATIONAL GMBH 347
16.7.1. COMPANY OVERVIEW 347
16.7.2. SANDOZ INTERNATIONAL GMBH: REVENUE ANALYSIS 347
16.7.3. PRODUCT PORTFOLIO 348
16.7.4. RECENT DEVELOPMENTS 348
16.8. PFIZER INC. 349
16.8.1. COMPANY OVERVIEW 349
16.8.2. PFIZER INC.: REVENUE ANALYSIS 349
16.8.3. PRODUCT PORTFOLIO 350
16.8.4. RECENT DEVELOPMENTS 350
16.9. SANOFI S.A. 351
16.9.1. COMPANY OVERVIEW 351
16.9.2. SANOFI S.A.: COMPANY REVENUE ANALYSIS 351
16.9.3. PRODUCT PORTFOLIO 352
16.9.4. RECENT DEVELOPMENTS 352
16.10. ASTRAZENECA 353
16.10.1. COMPANY OVERVIEW 353
16.10.2. ASTRAZENECA: REVENUE ANALYSIS 353
16.10.3. PRODUCT PORTFOLIO 354
16.10.4. RECENT DEVELOPMENTS 354
17. RELATED REPORTS 355
List of Figures, Tables and Charts Available in Europe Topical Corticosteroids Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024
TABLE LISTTABLE 1 PRICE OF VARIOUS PRODUCTS CONTAINING TOPICAL CORTICOSTEROIDS AND ANTIMICROBIALS 52
TABLE 2 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME,
2015– 2024 (USD MILLION) 61
TABLE 3 EUROPE FLUDROXYCORTIDE MARKET, BY REGION,
2015– 2024 (USD MILLION) 62
TABLE 4 EUROPE TRIAMCINOLONE ACETONIDE MARKET, BY REGION,
2015– 2024 (USD MILLION) 63
TABLE 5 EUROPE FLUOCINOLONE ACETONIDE MARKET, BY REGION,
2015– 2024 (USD MILLION) 64
TABLE 6 EUROPE ANTISEPTICS MARKET, BY REGION, 2015– 2024 (USD MILLION) 65
TABLE 7 EUROPE BETAMETHASONE MARKET, BY REGION, 2015– 2024 (USD MILLION) 66
TABLE 8 EUROPE CLOBETASONE PROPIONATE MARKET, BY REGION,
2015– 2024 (USD MILLION) 67
TABLE 9 EUROPE CLOBETASONE BUTYRATE MARKET, BY REGION,
2015– 2024 (USD MILLION) 68
TABLE 10 EUROPE HALOBETASONE MARKET, BY REGION, 2015– 2024 (USD MILLION) 69
TABLE 11 EUROPE MOMETASONE MARKET, BY REGION, 2015– 2024 (USD MILLION) 70
TABLE 12 EUROPE OTHERS MARKET, BY REGION, 2015– 2024 (USD MILLION) 71
TABLE 13 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS,
2015– 2024 (USD MILLION) 74
TABLE 14 EUROPE ULTRA HIGH POTENCY TOPICAL CORTICOSTEROIDS MARKET,
BY REGION, 2015-2024 (USD MILLION) 75
TABLE 15 EUROPE ULTRA HIGH POTENCY CLASS MARKET, BY TYPE,
2015– 2024 (USD MILLION) 76
TABLE 16 EUROPE HIGH POTENCY TOPICAL CORTICOSTEROIDS MARKET,
BY REGION, 2015 – 2024 (USD MILLION) 77
TABLE 17 EUROPE HIGH POTENCY CLASS MARKET, BY TYPE, 2015– 2024 (USD MILLION) 78
TABLE 18 EUROPE MODERATE TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 79
TABLE 19 EUROPE MODERATE HIGH POTENCY CLASS MARKET, BY TYPE,
2015– 2024 (USD MILLION) 80
TABLE 20 EUROPE MILD TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 82
TABLE 21 EUROPE MILD POTENCY CLASS MARKET, BY TYPE, 2015– 2024 (USD MILLION) 83
TABLE 22 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION,
2015 – 2024 (USD MILLION) 87
TABLE 23 EUROPE ACNE TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 88
TABLE 24 EUROPE DERMATITIS TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 89
TABLE 25 EUROPE PSORIASIS TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 90
TABLE 26 EUROPE SKIN INFECTION TOPICAL CORTICOSTEROIDS MARKET,
BY REGION, 2015 – 2024 (USD MILLION) 91
TABLE 27 EUROPE HYPERPIGMENTATION TOPICAL CORTICOSTEROIDS MARKET,
BY REGION, 2015 – 2024 (USD MILLION) 92
TABLE 28 EUROPE MELASMA TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 93
TABLE 29 EUROPE OTHERS TOPICAL CORTICOSTEROIDS APPLICATION MARKET,
BY REGION, 2015 – 2024 (USD BILLION) 94
TABLE 30 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE,
2015– 2024 (USD MILLION) 97
TABLE 31 EUROPE OINTMENT TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015-2024 (USD MILLION) 98
TABLE 32 EUROPE CREAMS TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 99
TABLE 33 EUROPE LIQUID & SOLUTIONS TOPICAL CORTICOSTEROIDS MARKET,
BY REGION, 2015 – 2024 (USD MILLION) 100
TABLE 34 EUROPE LOTIONS TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 101
TABLE 35 EUROPE GEL TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 102
TABLE 36 EUROPE OILS TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 103
TABLE 37 EUROPE PASTES TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 104
TABLE 38 EUROPE SPRAYS TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 105
TABLE 39 EUROPE OTHERS TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 106
TABLE 40 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY END-USER,
2015– 2024 (USD MILLION) 109
TABLE 41 EUROPE HOSPITAL TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 110
TABLE 42 EUROPE DERMATOLOGY CLINICS TOPICAL CORTICOSTEROIDS MARKET,
BY REGION, 2015 – 2024 (USD MILLION) 111
TABLE 43 EUROPE HOMECARE TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 112
TABLE 44 EUROPE OTHERS TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 113
TABLE 45 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015– 2024 (USD MILLION) 116
TABLE 46 EUROPE HOSPITAL PHARMACIES TOPICAL CORTICOSTEROIDS MARKET,
BY REGION, 2015 – 2024 (USD MILLION) 117
TABLE 47 EUROPE PHARMACY STORES TOPICAL CORTICOSTEROIDS MARKET,
BY REGION, 2015 – 2024 (USD MILLION) 118
TABLE 48 EUROPE ONLINE PHARMACIES TOPICAL CORTICOSTEROIDS MARKET,
BY REGION, 2015 – 2024 (USD MILLION) 119
TABLE 49 EUROPE OTHERS TOPICAL CORTICOSTEROIDS MARKET, BY REGION,
2015 – 2024 (USD MILLION) 120
TABLE 50 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE,
2015– 2024 (USD MILLION) 123
TABLE 51 EUROPE OVER THE COUNTER (OTC) BASED TOPICAL CORTICOSTEROIDS MARKET, BY REGION, 2015-2024 (USD MILLION) 124
TABLE 52 EUROPE PRESCRIPTION BASED TOPICAL CORTICOSTEROIDS MARKET,
BY REGION, 2015 – 2024 (USD MILLION) 125
TABLE 53 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY COUNTRY,
2015 – 2024 (USD MILLION) 137
TABLE 54 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY COUNTRY,
2015– 2024 (USD MILLION) 173
TABLE 55 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME,
2015– 2024 (USD MILLION) 174
TABLE 56 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE,
2015– 2024 (USD MILLION) 175
TABLE 57 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION,
2015-2024 (USD MILLION) 175
TABLE 58 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE,
2015-2024 (USD MILLION) 176
TABLE 59 EUROPE TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS,
2015– 2024 (USD MILLION) 177
TABLE 60 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY END USER,
2015-2024 (USD MILLION) 177
TABLE 61 EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) 178
TABLE 62 GERMANY TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME,
2015– 2024 (USD MILLION) 179
TABLE 63 GERMANY TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE,
2015– 2024 (USD MILLION) 180
TABLE 64 GERMANY TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION,
2015-2024 (USD MILLION) 180
TABLE 65 GERMANY TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE,
2015-2024 (USD MILLION) 181
TABLE 66 GERMANY TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS,
2015– 2024 (USD MILLION) 182
TABLE 67 GERMANY TOPICAL CORTICOSTEROIDS MARKET, BY END USER,
2015-2024 (USD MILLION) 182
TABLE 68 GERMANY TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) 183
TABLE 69 FRANCE TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME,
2015– 2024 (USD MILLION) 184
TABLE 70 FRANCE TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE,
2015– 2024 (USD MILLION) 185
TABLE 71 FRANCE TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION,
2015-2024 (USD MILLION) 185
TABLE 72 FRANCE TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE,
2015-2024 (USD MILLION) 186
TABLE 73 FRANCE TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS,
2015– 2024 (USD MILLION) 187
TABLE 74 FRANCE TOPICAL CORTICOSTEROIDS MARKET, BY END USER,
2015-2024 (USD MILLION) 187
TABLE 75 FRANCE TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) 188
TABLE 76 U.K. TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME,
2015– 2024 (USD MILLION) 189
TABLE 77 U.K. TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE,
2015– 2024 (USD MILLION) 190
TABLE 78 U.K. TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION,
2015-2024 (USD MILLION) 190
TABLE 79 U.K. TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE,
2015-2024 (USD MILLION) 191
TABLE 80 U.K. TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS,
2015– 2024 (USD MILLION) 192
TABLE 81 U.K. TOPICAL CORTICOSTEROIDS MARKET, BY END USER,
2015-2024 (USD MILLION) 192
TABLE 82 U.K. TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL,
2015-2024 (USD MILLION) 193
TABLE 83 ITALY TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME,
2015– 2024 (USD MILLION) 194
TABLE 84 ITALY TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE,
2015– 2024 (USD MILLION) 195
TABLE 85 ITALY TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION,
2015-2024 (USD MILLION) 195
TABLE 86 ITALY TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE,
2015-2024 (USD MILLION) 196
TABLE 87 ITALY TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS,
2015– 2024 (USD MILLION) 197
TABLE 88 ITALY TOPICAL CORTICOSTEROIDS MARKET, BY END USER,
2015-2024 (USD MILLION) 197
TABLE 89 ITALY TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) 198
TABLE 90 SPAIN TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME,
2015– 2024 (USD MILLION) 199
TABLE 91 SPAIN TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE,
2015– 2024 (USD MILLION) 200
TABLE 92 SPAIN TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION,
2015-2024 (USD MILLION) 200
TABLE 93 SPAIN TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE,
2015-2024 (USD MILLION) 201
TABLE 94 SPAIN TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS,
2015– 2024 (USD MILLION) 202
TABLE 95 SPAIN TOPICAL CORTICOSTEROIDS MARKET, BY END USER,
2015-2024 (USD MILLION) 202
TABLE 96 SPAIN TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) 203
TABLE 97 RUSSIA TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME,
2015– 2024 (USD MILLION) 204
TABLE 98 RUSSIA TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE,
2015– 2024 (USD MILLION) 205
TABLE 99 RUSSIA TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION,
2015-2024 (USD MILLION) 205
TABLE 100 RUSSIA TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE,
2015-2024 (USD MILLION) 206
TABLE 101 RUSSIA TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS,
2015– 2024 (USD MILLION) 207
TABLE 102 RUSSIA TOPICAL CORTICOSTEROIDS MARKET, BY END USER,
2015-2024 (USD MILLION) 207
TABLE 103 RUSSIA TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) 208
TABLE 104 TURKEY TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME,
2015– 2024 (USD MILLION) 209
TABLE 105 TURKEY TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE,
2015– 2024 (USD MILLION) 210
TABLE 106 TURKEY TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION,
2015-2024 (USD MILLION) 210
TABLE 107 TURKEY TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE,
2015-2024 (USD MILLION) 211
TABLE 108 TURKEY TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS,
2015– 2024 (USD MILLION) 212
TABLE 109 TURKEY TOPICAL CORTICOSTEROIDS MARKET, BY END USER,
2015-2024 (USD MILLION) 212
TABLE 110 TURKEY TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) 213
TABLE 111 BELGIUM TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME,
2015– 2024 (USD MILLION) 214
TABLE 112 BELGIUM TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE,
2015– 2024 (USD MILLION) 215
TABLE 113 BELGIUM TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION,
2015-2024 (USD MILLION) 215
TABLE 114 BELGIUM TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE,
2015-2024 (USD MILLION) 216
TABLE 115 BELGIUM TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS,
2015– 2024 (USD MILLION) 217
TABLE 116 BELGIUM TOPICAL CORTICOSTEROIDS MARKET, BY END USER,
2015-2024 (USD MILLION) 217
TABLE 117 BELGIUM TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) 218
TABLE 118 NETHERLANDS TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION) 219
TABLE 119 NETHERLANDS TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION) 220
TABLE 120 NETHERLANDS TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION,
2015-2024 (USD MILLION) 220
TABLE 121 NETHERLANDS TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) 221
TABLE 122 NETHERLANDS TOPICAL CORTIOCOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION) 222
TABLE 123 NETHERLANDS TOPICAL CORTICOSTEROIDS MARKET, BY END USER,
2015-2024 (USD MILLION) 222
TABLE 124 NETHERLANDS TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) 223
TABLE 125 SWITZERLAND TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION) 224
TABLE 126 SWITZERLAND TOPICAL CORTICOSTEROIDS MARKET, BY PURCHASE MODE, 2015– 2024 (USD MILLION) 225
TABLE 127 SWITZERLAND TOPICAL CORTICOSTEROIDS MARKET, BY APPLICATION,
2015-2024 (USD MILLION) 225
TABLE 128 SWITZERLAND TOPICAL CORTICOSTEROIDS MARKET, BY MEDICATION TYPE, 2015-2024 (USD MILLION) 226
TABLE 129 SWITZERLAND TOPICAL CORTICOSTEROIDS MARKET, BY POTENCY CLASS, 2015– 2024 (USD MILLION) 227
TABLE 130 SWITZERLAND TOPICAL CORTICOSTEROIDS MARKET, BY END USER,
2015-2024 (USD MILLION) 227
TABLE 131 SWITZERLAND TOPICAL CORTICOSTEROIDS MARKET, BY DISTRIBUTION CHANNEL, 2015-2024 (USD MILLION) 228
TABLE 132 REST OF EUROPE TOPICAL CORTICOSTEROIDS MARKET, BY MOLECULE NAME, 2015– 2024 (USD MILLION) 229
FIGURES LIST
FIGURE 1 EUROPE TOPICAL CORTICOSTEROIDS MARKET: SEGMENTATION 38
FIGURE 2 EUROPE TOPICAL CORTICOSTEROIDS MARKET: DATA TRIANGULATION 42
FIGURE 3 EUROPE TOPICAL CORTICOSTEROIDS MARKET: RESEARCH SNAPSHOT 43
FIGURE 4 EUROPE TOPICAL CORTICOSTEROIDS MARKET : BOTTOM UP APPROACH 45
FIGURE 5 EUROPE TOPICAL CORTICOSTEROIDS MARKET : TOP DOWN APPROACH 45
FIGURE 6 EUROPE TOPICAL CORTICOSTEROIDS MARKET: INTERVIEW DEMOGRAPHICS 46
FIGURE 7 EUROPE TOPICAL CORTICOSTEROIDS MARKET: BY MOLECULE NAME, SNAPSHOT 2016 60
FIGURE 8 EUROPE TOPICAL CORTICOSTEROIDS MARKET: BY POTENCY CLASS, 2016 73
FIGURE 9 EUROPE TOPICAL CORTICOSTEROIDS MARKET: BY APPLICATION, 2016 86
FIGURE 10 EUROPE TOPICAL CORTICOSTEROIDS MARKET: BY MEDICATION TYPE, 2016 96
FIGURE 11 EUROPE TOPICAL CORTICOSTEROIDS MARKET: BY END-USER, 2016 108
FIGURE 12 EUROPE TOPICAL CORTICOSTEROIDS MARKET:
BY DISTRIBUTION CHANNEL, 2016 115
FIGURE 13 EUROPE TOPICAL CORTICOSTEROIDS MARKET: BY PURCHASE MODE, 2016 122
FIGURE 14 EUROPE TOPICAL CORTICOSTEROIDS MARKET SNAPSHOT (2016) 132
FIGURE 15 EUROPE TOPICAL CORTICOSTEROIDS MARKET: BY GEOGRAPHY (2016) 133
FIGURE 16 EUROPE TOPICAL CORTICOSTEROIDS MARKET: BY GROGRAPHY (2017 & 2024) 134
FIGURE 17 EUROPE TOPICAL CORTICOSTEROIDS MARKET: BY GEOGRAPHY (2016 & 2024) 135
FIGURE 18 EUROPE TOPICAL CORTICOSTEROIDS MARKET,
BY MOLECULE NAME (2017 & 2024) 136
FIGURE 19 EUROPE TOPICAL CORTICOSTEROIDS MARKET SNAPSHOT (2016) 168
FIGURE 20 EUROPE TOPICAL CORTICOSTEROIDS MARKET : BY COUNTRY (2016) 169
FIGURE 21 EUROPE TOPICAL CORTICOSTEROIDS MARKET:BY COUNTRY (2017 & 2024) 170
FIGURE 22 EUROPE TOPICAL CORTICOSTEROIDS MARKET BY COUNTRY (2016 & 2024) 171
FIGURE 23 EUROPE TOPICAL CORTICOSTEROIDS MARKET,
BY MOLECULE NAME (2017 & 2024) 172
FIGURE 24 EUROPE TOPICAL CORTICOSTEROIDS MARKET: COMPANY SHARE 2016 (%) 331
FIGURE 25 EUROPE TOPICAL CORTICOSTEROIDS MARKET: COMPANY SHARE 2016 (%) 333
Keyplayers in Europe Topical Corticosteroids Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024
• LEO Pharma• Glaxosmithkline Plc,
• Pfizer Inc.
Request Sample
Request Discount
